Discover
Stocks
Consumer Goods
NBIX
NBIX
Neurocrine Biosciences Inc
119.47
0.93
(
0.78%
)
Market Closed
Delayed Prices By NASDAQ,
in USD
Trade
Buy
NBIX
Neurocrine Biosciences Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Neurocrine Biosciences Inc's revenues increased by 31.34% and amounted to 1.49B. Net income increased by 72.43% to 154.50M. Net assets increased by 24.29% to 1.71B and EPS increased from 0.92 to 1.56.
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment